Gainers
- TherapeuticsMD TXMD shares rose 4466.2% to $7.0 during Monday's pre-market session. The company's market cap stands at $60.6 million.
- Better Therapeutics BTTX stock rose 33.51% to $2.51. The market value of their outstanding shares is at $59.2 million.
- LogicBio Therapeutics LOGC shares moved upwards by 30.88% to $0.65. The market value of their outstanding shares is at $21.4 million.
- FibroGen FGEN stock rose 10.46% to $9.29. The company's market cap stands at $866.6 million. As per the press release, Q1 earnings came out today.
- Palisade Bio PALI shares moved upwards by 8.88% to $0.56. The market value of their outstanding shares is at $10.2 million.
- Surface Oncology SURF stock rose 8.61% to $2.27. The company's market cap stands at $123.9 million.
Losers
- The Oncology Institute TOI shares declined by 21.7% to $6.9 during Monday's pre-market session. The market value of their outstanding shares is at $505.4 million.
- ContraFect CFRX shares fell 14.03% to $3.25. The market value of their outstanding shares is at $127.8 million.
- GlucoTrack GCTK stock fell 13.93% to $2.41. The market value of their outstanding shares is at $37.2 million.
- Reshape Lifesciences RSLS stock decreased by 11.83% to $0.67. The company's market cap stands at $2.3 million.
- Immuron IMRN shares declined by 11.12% to $2.5. The market value of their outstanding shares is at $14.2 million.
- Avenue Therapeutics ATXI shares decreased by 11.03% to $0.3. The market value of their outstanding shares is at $6.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in